• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk factors for death in patients with beta-thalassemia major: results of a case-control study.

作者信息

Ceci Adriana, Baiardi Paola, Catapano Mariana, Felisi Mariagrazia, Cianciulli Paolo, De Sanctis Vincenzo, Del Vecchio Giovanni Carlo, Magnano Carmelo, Meo Anna, Maggio Aurelio

出版信息

Haematologica. 2006 Oct;91(10):1420-1. Epub 2006 Sep 7.

PMID:16963395
Abstract

This retrospective one to one matched case-control study was aimed at evaluating risk factors for death in beta-thalassemic patients followed in Italian centers between 1997 and 2001. The mortality risk was lower in patients with good compliance to iron chelation therapy and in those treated with deferiprone.

摘要

相似文献

1
Risk factors for death in patients with beta-thalassemia major: results of a case-control study.
Haematologica. 2006 Oct;91(10):1420-1. Epub 2006 Sep 7.
2
Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.性腺功能减退、糖尿病、甲状腺功能减退、甲状旁腺功能减退：1980年至2007年在费拉拉中心随访的重型地中海贫血患者中与铁过载及螯合疗法相关的发病率和患病率
Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:158-69.
3
Survival of thalassemic patients referred to the Boo Ali Sina Teaching Hospital, Sari, Iran.转诊至伊朗萨里布阿里·西纳教学医院的地中海贫血患者的生存率。
Hemoglobin. 2007;31(4):453-62. doi: 10.1080/03630260701641294.
4
Severe iron overload in Blackfan-Diamond anemia: a case-control study.黑范-戴蒙德贫血中的严重铁过载：一项病例对照研究。
Am J Hematol. 2009 Nov;84(11):729-32. doi: 10.1002/ajh.21541.
5
Zinc status in patients with major beta-thalassemia.重型β地中海贫血患者的锌状态
Pediatr Hematol Oncol. 2008 Jan-Feb;25(1):49-54. doi: 10.1080/08880010701773738.
6
Nitroblue tetrazolium test in patients with beta-thalassemia major.
Saudi Med J. 2008 Nov;29(11):1601-5.
7
Early impairment of myocardial function in young patients with beta-thalassemia major.重型β地中海贫血年轻患者的心肌功能早期损害
Eur J Haematol. 2008 Jun;80(6):515-22. doi: 10.1111/j.1600-0609.2008.01054.x. Epub 2008 Feb 12.
8
Bone metabolism and mineral density in patients with beta-thalassemia major.重型β地中海贫血患者的骨代谢与骨密度
Saudi Med J. 2007 Sep;28(9):1425-9.
9
Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.水飞蓟素与去铁胺联合治疗重型β地中海贫血患者：一项随机双盲临床试验。
Fundam Clin Pharmacol. 2009 Jun;23(3):359-65. doi: 10.1111/j.1472-8206.2009.00681.x. Epub 2009 May 7.
10
Evaluation of survival in medically treated patients with homozygous beta thalassemia by the quick hit method.
J Insur Med. 1994;26(4):403-4.

引用本文的文献

1
Unrelated donor stem cell transplantation for transfusion-dependent thalassemia.无关供者干细胞移植治疗依赖输血的地中海贫血
Ann N Y Acad Sci. 2016 Mar;1368(1):122-6. doi: 10.1111/nyas.13019. Epub 2016 Mar 21.
2
Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia.去铁酮治疗输血依赖型地中海贫血患者的安全性和有效性。
Ther Adv Hematol. 2012 Oct;3(5):299-307. doi: 10.1177/2040620712450252.
3
Treating thalassemia major-related iron overload: the role of deferiprone.治疗重型地中海贫血相关的铁过载：去铁酮的作用
J Blood Med. 2012;3:119-29. doi: 10.2147/JBM.S27400. Epub 2012 Oct 19.
4
Management of transfusional iron overload - differential properties and efficacy of iron chelating agents.输血性铁过载的管理——铁螯合剂的差异特性与疗效
J Blood Med. 2011;2:135-49. doi: 10.2147/JBM.S13065. Epub 2011 Sep 21.
5
On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure.地中海贫血症患者铁螯合治疗对射血分数的改善作用和未来心力衰竭风险。
J Cardiovasc Magn Reson. 2011 Sep 12;13(1):45. doi: 10.1186/1532-429X-13-45.
6
The management of iron chelation therapy: preliminary data from a national registry of thalassaemic patients.铁螯合疗法的管理：来自全国地中海贫血患者登记处的初步数据。
Anemia. 2011;2011:435683. doi: 10.1155/2011/435683. Epub 2011 Jun 5.
7
Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging.地拉罗司、去铁酮和去铁胺治疗地中海贫血症患者：通过定量磁共振成像评估心脏铁含量和功能的比较。
Haematologica. 2011 Jan;96(1):41-7. doi: 10.3324/haematol.2009.019042. Epub 2010 Sep 30.
8
Beta-thalassemia.β-地中海贫血。
Orphanet J Rare Dis. 2010 May 21;5:11. doi: 10.1186/1750-1172-5-11.
9
Deferasirox : a review of its use in the management of transfusional chronic iron overload.地拉罗司：用于治疗输血所致慢性铁过载的综述
Drugs. 2007;67(15):2211-30. doi: 10.2165/00003495-200767150-00007.
10
Optimal management strategies for chronic iron overload.慢性铁过载的最佳管理策略。
Drugs. 2007;67(5):685-700. doi: 10.2165/00003495-200767050-00004.